Schedule 13D ownership disclosure

THESEUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88369M101

Event date: 2023-11-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950142-23-002837
Form type
SC 13D/A
Filer
Foresite Capital Fund V, L.P.
CIK
CIK 1792204
Filed
Nov 24, 2023
Reporting period
Nov 22, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub